Gain insights about the health of your baby during pregnancy
Noninvasive prenatal screening (NIPS/NIPT) tests can screen for trisomy 21 (Down syndrome) and other chromosomal abnormalities—as well as the sex of your baby—as early as nine weeks into your pregnancy, and with a high degree of accuracy.
GENOME-Flex, a new NIPS (NIPT) high risk pathway. Rapidly re-sequence previously run MaterniT 21 PLUS samples using MaterniT GENOME when late stage anomalies are suspected. Now you have options if a second NIPS (NIPT) is required.
This video explains what your MaterniT results mean and what next steps or other testing you might consider.
NOTE: The American College of Obstetricians and Gynecologists recommends that women with a “high risk” maternal serum screening result be offered diagnostic testing.1 Women with a “low risk” result often choose not to have diagnostic testing.
NOTE: Not even diagnostic testing can show all birth defects or genetic diseases. No test is perfect: even when all the results of diagnostic testing are normal, all pregnancies still have approximately a 3-5% risk of birth defects.